Related Experiment Video
Updated: Sep 13, 2025

Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
Prognostic impact of atrio-ventricular conduction abnormalities in non-ischemic cardiomyopathy
Javier Sanaú1, Andrea Di Marco1, Pamela Brown2
1Department of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Bioheart-Cardiovascular Diseases Group, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Spain.
Insights
Atrioventricular block (AVB) predicts ventricular arrhythmias (VA) in non-ischemic cardiomyopathy (NICM), especially when combined with late gadolinium enhancement (LGE). This finding aids risk stratification for sudden cardiac death.
Area of Science:
- Cardiology
- Cardiac Imaging
- Electrophysiology
Background:
- Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) aids ventricular arrhythmia (VA) prediction in non-ischemic cardiomyopathy (NICM).
- Risk stratification within LGE-positive (LGE+) NICM patients remains challenging.
- Atrioventricular block (AVB) is a potential VA predictor, but contemporary data are limited.
Purpose of the Study:
- To evaluate the prognostic significance of AVB in a current cohort of NICM patients undergoing CMR.
- To determine if AVB improves risk stratification for VA in NICM.
Main Methods:
- Retrospective cohort study of 616 NICM patients.
- Assessment of AVB via electrocardiogram (ECG) and LGE via CMR.
- Primary endpoint: VA (arrhythmia events, sudden death); Secondary endpoint: heart failure (HF) events.
Main Results:
- AVB occurred in 9% of patients, associated with lower LVEF and higher LGE prevalence.
- AVB independently predicted VA events (HR 2.7, P=.007) alongside LGE and LVEF.
- In LGE+ patients, AVB significantly increased VA risk (aHR 3.4, P<.001).
- AVB did not predict HF events (P=.11).
Conclusions:
- AVB is a strong, independent predictor of VA and sudden death in NICM, complementing LGE and LVEF.
- AVB significantly refines risk stratification in LGE+ NICM patients.
- AVB identifies a subgroup of NICM patients at extremely high risk for arrhythmias.
Background:
Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) improves prediction of ventricular arrhythmias (VA) in non-ischemic cardiomyopathy (NICM), but risk stratification within LGE+ cases remains challenging. Atrioventricular block (AVB) has been proposed as a predictor of VA, but contemporary data are scarce.
Objective:
To assess the prognostic value of AVB in a contemporary cohort of patients with NICM studied with CMR.
Methods:
Retrospective cohort study including 616 patients with NICM, with assessment of AVB at electrocardiogram (ECG) and LGE at CMR. The primary arrhythmic end point included any appropriate implantable cardioverter defibrillator therapy, sustained monomorphic ventricular tachycardia, resuscitated cardiac arrest, and sudden death. The secondary heart failure (HF) end point included HF hospitalization, heart transplant, left ventricular assist device implant, and death due to end-stage HF.
Results:
AVB was observed in 9% of patients and was associated with more severe cardiac dysfunction (left ventricular ejection fraction [LVEF] 29% vs 37%, P < .001) and higher prevalence of LGE (63% vs 46%, P = .02). AVB independently predicted the combined arrhythmic end point in addition to LGE and LVEF (hazard ratio [HR], 2.7; P = .007), and was particularly impactful when present alongside LGE; among LGE+ patients, AVB significantly increased the risk of the primary end point (adjusted HR 3.4, P < .001). In contrast, AV block was not a significant predictor of the HF end point at multivariate analysis (P = .11).
Conclusion:
AVB is a strong and independent predictor of VA and sudden death in NICM, in addition to LGE and LVEF. In addition, AVB has a significant impact on the risk stratification of LGE+ cases, identifying a small sub-group of patients with extremely high arrhythmic risk.
More Related Videos
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Mechanism of Cardiac Arrhythmias